Skip to content

Medical-device intelligence

OZE: Influenza A And Influenza B Multiplex Nucleic Acid Assay

FDA product code OZE: Influenza A And Influenza B Multiplex Nucleic Acid Assay. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
OZE
FDA device name
Influenza A And Influenza B Multiplex Nucleic Acid Assay
Device class
2
Regulation number
866.3980
Medical specialty
Microbiology
Review panel
MI

FDA definition

An Influenza A and Influenza B multiplex nucleic acid assay is a multiplex in vitro diagnostic test for the simultaneous qualitative detection and discrimination of influenza A and influenza B nucleic acids isolated and purified from human respiratory specimens obtained from individuals exhibiting signs and symptoms of respiratory tract infections or viral culture. The detection and discrimination of influenza A and B nucleic acids from symptomatic patients aid in the diagnosis of human respiratory tract influenza viral infections if used in conjunction with other clinical and laboratory findings.
Explore microbiology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

21 clearance records and 5 recall records in the covered releases, across 10 source company names and 1 product codes. Dated history runs from Mar 15, 2012 to Sep 30, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202601
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202610
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
OZE · Influenza A And Influenza B Multiplex Nucleic Acid Assay215

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

26 matching records
Device / recordCompany in FDA recordSourceSource date
QUIDEL MOLECULAR INFLUENZA A+BK113777 · OZEQuidel Corp.510(k)Mar 15, 2012FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗